# FOXO1 Inhibition and FADD Knockdown Have Opposing Effects on Anticancer Drug-Induced Cytotoxicity and p21 Expression in Osteosarcoma Cells

**Authors:** Danielle Walker, Antanay Hall, Alexis Bonwell, Nancy Gordon, Danielle Robinson, Mario G. Hollomon

PMC · DOI: 10.3390/ijms27020935 · International Journal of Molecular Sciences · 2026-01-17

## TL;DR

This study shows that FOXO1 and FADD have opposing effects on cancer drug responses and cell cycle control in osteosarcoma cells.

## Contribution

The study reveals that FOXO1 acts as a tumor suppressor while FADD promotes tumor growth in response to anticancer drugs in osteosarcoma.

## Key findings

- FOXO1 inhibition reverses anticancer drug-induced cytotoxicity and causes G2/M cell cycle arrest.
- FADD knockdown increases drug-induced cytotoxicity and reverses the effect of FOXO1 inhibition on p21 expression.
- Higher FOXO1 levels correlate with increased sensitivity to camptothecin in osteosarcoma cells.

## Abstract

Forkhead box class O1 (FOXO1) and fas-associated death domain (FADD) regulate cell death pathways and homeostatic processes such as cell cycle progression and apoptosis. FADD phosphorylation promotes nuclear localization of FOXO1, and FOXO1 regulates FADD expression. Therefore, it is plausible that FOXO1 and FADD have synergistic or antagonistic effects on cell cycle regulation and the response to anticancer drug treatment in cancer cells. In the present study, we report that AS1842856-mediated inhibition of FOXO1 reverses anticancer drug-induced cytotoxicity, while FADD knockdown increases anticancer drug-induced cytotoxicity in osteosarcoma (OS). Reversed anticancer drug-induced cytotoxicity was accompanied by G2/M cell cycle arrest and increased expression of p21. The anticancer function of FOXO1 was further supported by the observation that OS cells that express higher basal levels of FOXO1 had increased sensitivity to camptothecin-induced cytotoxicity. FADD knockdown reversed the FOXO1 inhibition-induced increase in p21 expression. The results presented in this study indicate that FOXO1 has a tumor suppressor function, while FADD has a tumor-promoting function in OS following anticancer drug treatment. The experimental approach used in this investigation also indicates that FADD antagonizes the effect of FOXO1 on p21 expression in OS.

## Linked entities

- **Genes:** FOXO1 (forkhead box O1) [NCBI Gene 2308], FADD (Fas associated via death domain) [NCBI Gene 8772], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026]
- **Proteins:** FOXO1 (forkhead box O1), FADD (Fas associated via death domain)
- **Chemicals:** AS1842856 (PubChem CID 72193864), camptothecin (PubChem CID 2538)
- **Diseases:** osteosarcoma (MONDO:0002623)

## Full-text entities

- **Genes:** H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}
- **Diseases:** OS (MESH:D012516), Cytotoxicity (MESH:D064420), cancer (MESH:D009369)
- **Chemicals:** camptothecin (MESH:D002166), AS1842856 (MESH:C553926)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12842461/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12842461/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12842461/full.md

---
Source: https://tomesphere.com/paper/PMC12842461